| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B |
| Cost of Revenue | – | – | – | $743.99M | $650.26M |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $277.92M | $307.27M | $348.52M | $333.63M | $311.88M |
| SG&A | $431.89M | $435.49M | $464.66M | $449.86M | $438.01M |
| Operating Income | -$262.95M | -$1.02B | -$248.55M | -$13.65B | -$265.63M |
| Interest Expense | – | $23.80M | $22.28M | $21.94M | $81.14M |
| Tax Expense | -$35.21M | $7.59M | $760.00K | -$3.81M | $44.14M |
| Net Income | -$200.32M | -$1.00B | -$220.37M | -$13.66B | -$428.79M |
| EPS (basic) | -1.1400 | -5.8700 | -1.3400 | -84.6000 | -2.7300 |
| EPS (diluted) | -1.1400 | -5.8700 | -1.3400 | -84.6000 | -2.7300 |
| Shares (diluted) | $176.22M | $170.56M | $164.58M | $161.46M | $156.94M |